Reimagining Biologically Adapted Somatostatin Receptor-Targeted Radionuclide Therapy: Perspectives Based on Personal Experience and Observations on Recent Trials

Affiliations

• ¹ Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France; david.taieb@ap-hm.fr.
• ² ERL INSERM U1326 "RNAnoTher", CNRS, Aix-Marseille University, Marseille, France.
• ³ Gustave Roussy, University of Paris-Saclay, Villejuif, France.
• ⁴ Department of Medicine, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia; and.
• ⁵ Department of Medicine, Central Clinical School, Alfred Hospital, Monash University, Melbourne, Victoria, Australia.